Comparison of chemoport and Hickman central venous catheters in patients with hematological cancer
For immunocompromised patients with hematological malignancies, chemoport usage may reduce the occurrence of infections, ensuring the long-term maintenance of vascular access. Furthermore, the average reinsertion rate of both groups was confirmed to be more than 1. Therefore, performing the stem cell transplantation procedure using Hickman CVC and then changing to chemoport for subsequent chemotherapy can minimize the infection risk and safely preserve long-term vascular access. Additionally, the overall complication rate can be reduced through accurate CVC insertion methods using vascular imaging and routine management by medical professionals.
Authors
- Jonggeun Lee (ORCID: https://orcid.org/0000-0003-3797-8582)
- Up Huh (ORCID: https://orcid.org/0000-0002-7739-3979)
- Changsung Han (ORCID: https://orcid.org/0000-0003-3665-8982)
- Chung Won Lee (ORCID: https://orcid.org/0000-0002-1160-6003)
- Miju Bae (ORCID: https://orcid.org/0000-0003-1555-4113)
- Gwon-Min Kim (ORCID: https://orcid.org/0000-0001-7901-3506)
- Jong‐Hwan Park (ORCID: https://orcid.org/0000-0003-2815-7248)
- Do Young Kim (ORCID: https://orcid.org/0000-0002-5601-9427)
- Jong‐Won Kim (ORCID: https://orcid.org/0000-0002-0708-9242)
- Ho Jin Shin
Institutions
- Pusan National University Hospital (KR)
- Pusan National University (KR)
Publication Details
- Journal
- Translational Cancer Research
- Published
- 2025-04-01
- DOI
- https://doi.org/10.21037/tcr-24-2147
- Citations
- 2
- Primary Topic
- Central Venous Catheters and Hemodialysis
- Type
- article
- Field-Weighted Citation Impact
- 5.03